Sample inventory management is a continuous process that supports the integrity of your data and research. Yet with samples and critical reagents added over time, sprawling inventories can strain valuable time, energy, and resources. An objective inventory review, conducted by better storage management experts, can help to optimize your sample and material storage and sustain […]
View Blog
The last decade has seen a revolution in the way cell and gene therapies are developed, delivered, and accessed. What began as pioneering work in bone marrow transplantation has evolved into a global ecosystem advancing engineered cell therapies that offer new hope to patients facing devastating diseases. This transformation—rooted in science, collaboration, and compassion—continues to […]
View Blog
Proper storage of biological assets is vital to keep your research moving forward. Yet, while you focus on research activities, it’s all too common for sample and critical reagent inventories to morph into an unorganized sprawl. The most obvious impact is time spent finding your materials of interest, but there are other consequences to sample […]
View Blog
Access to advanced therapies is often framed as a challenge of resources and infrastructure. But in Europe, a bold new model is reshaping how patients receive life-saving CAR T-cell therapy. Instead of relying solely on commercial manufacturing and centralized approval processes, the Hospital Clínic de Barcelona has pioneered a hospital-based pathway that delivers CAR-T directly […]
View Blog
A Strategic Guide for U.S. Pharmaceutical Manufacturers As more pharmaceutical companies bring drug manufacturing stateside, a critical but often under-planned question arises: what happens to your product after it leaves the manufacturing floor? For products requiring strict temperature control and regulatory compliance, storage isn’t just about holding space. It’s about protecting product integrity, meeting regulatory […]
View Blog
Cell and gene therapy (CGT) manufacturing can be complex. Part of the process requires precise, contamination-free thawing across a variety of critical materials. While we often focus on thawing cryopreserved cell products, another key component in CGT workflows is the controlled thawing of viral vectors used in gene modification. Researchers of King’s College London, UK, […]
View Blog
During cell therapy process development and manufacturing, you need unwavering trust in the technologies that you use. Barkey offers multiple solutions that deliver trust in the form of precise, gentle, yet robust dry thawing for your vials, bags, and bottles. Below are 10 great reasons to incorporate a Barkey dry thawing system. 10 Reasons to […]
View Blog
Providing access to transformative cell and gene therapies is one of the most urgent challenges in modern healthcare. These treatments offer the possibility of curing conditions once thought untreatable—yet in the United States, only a fraction of eligible patients are receiving them. The barriers are complex: financial risk for payers, short-term budgeting in a long-term […]
View Blog
Access to life-saving cell and gene therapies is one of the most critical challenges facing healthcare today. While these therapies offer remarkable hope for patients battling life-threatening conditions like cancer and rare genetic diseases, the reality is that only a fraction of eligible patients are actually receiving them. The reasons are rarely scientific. More often, […]
View Blog
In the rapidly advancing world of cell and gene therapy, a single treatment can alter a patient’s life trajectory. But what happens after the initial success? For many, the journey is just beginning. Long-term follow-up (LTFU) is not just a regulatory requirement—it’s a vital, ethical commitment to patients who become pioneers of new treatments. Yet, […]
View Blog